News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
730,199 Results
Type
Article (42791)
Company Profile (280)
Press Release (687118)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (206861)
Career Advice (2052)
Deals (35845)
Drug Delivery (110)
Drug Development (81762)
Employer Resources (173)
FDA (16545)
Job Trends (15141)
News (349796)
Policy (33188)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2649)
Academic (1)
Accelerated approval (31)
Adcomms (24)
Allergies (142)
Alliances (50391)
ALS (169)
Alzheimer's disease (1679)
Antibody-drug conjugate (ADC) (308)
Approvals (16806)
Artificial intelligence (514)
Autoimmune disease (151)
Automation (38)
Bankruptcy (365)
Best Places to Work (11711)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (179)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (636)
Cancer (4806)
Cardiovascular disease (403)
Career advice (1736)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (741)
Cervical cancer (37)
Clinical research (69735)
Collaboration (1708)
Company closure (4)
Compensation (1152)
Complete response letters (54)
COVID-19 (2759)
CRISPR (88)
C-suite (840)
Cystic fibrosis (143)
Data (6208)
Decentralized trials (2)
Denatured (26)
Depression (132)
Diabetes (500)
Diagnostics (6864)
Digital health (47)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90556)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (118080)
Executive appointments (976)
FDA (19649)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1477)
Gene editing (195)
Generative AI (43)
Gene therapy (594)
GLP-1 (977)
Government (4704)
Grass and pollen (6)
Guidances (383)
Healthcare (19008)
HIV (59)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (249)
Immuno-oncology (56)
Indications (109)
Infectious disease (3026)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (115)
Intellectual property (247)
Interviews (319)
IPO (16712)
IRA (49)
Job creations (3764)
Job search strategy (1454)
JPM (58)
Kidney cancer (15)
Labor market (84)
Layoffs (551)
Leadership (31)
Legal (8066)
Liver cancer (91)
Longevity (14)
Lung cancer (648)
Lymphoma (374)
Machine learning (42)
Management (59)
Manufacturing (791)
MASH (163)
Medical device (13830)
Medtech (13883)
Mergers & acquisitions (20204)
Metabolic disorders (1266)
Multiple sclerosis (160)
NASH (17)
Neurodegenerative disease (314)
Neuropsychiatric disorders (87)
Neuroscience (2904)
Neurotech (1)
NextGen: Class of 2026 (6558)
Non-profit (4569)
Now hiring (67)
Obesity (594)
Opinion (261)
Ovarian cancer (167)
Pain (197)
Pancreatic cancer (227)
Parkinson's disease (280)
Partnered (34)
Patents (492)
Patient recruitment (482)
Peanut (57)
People (59502)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21755)
Phase 2 (30673)
Phase 3 (22855)
Pipeline (5231)
Policy (279)
Postmarket research (2585)
Preclinical (9317)
Press Release (67)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (280)
Rare diseases (831)
Real estate (6168)
Recruiting (70)
Regulatory (24779)
Reports (52)
Research institute (2450)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (147)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (44)
Startups (3660)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (998)
Venture capital (87)
Weight loss (381)
Women's health (89)
Worklife (18)
Date
Today (119)
Last 7 days (618)
Last 30 days (2058)
Last 365 days (30013)
2026 (3202)
2025 (30316)
2024 (35420)
2023 (40334)
2022 (51426)
2021 (56017)
2020 (54500)
2019 (46966)
2018 (35323)
2017 (32519)
2016 (31979)
2015 (38001)
2014 (31864)
2013 (26985)
2012 (29107)
2011 (29783)
2010 (27820)
Location
Africa (753)
Alabama (83)
Alaska (7)
Arizona (311)
Arkansas (13)
Asia (40023)
Australia (6548)
California (11265)
Canada (3278)
China (1099)
Colorado (478)
Connecticut (473)
Delaware (335)
Europe (86541)
Florida (1678)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (857)
India (64)
Indiana (520)
Iowa (22)
Japan (425)
Kansas (125)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1382)
Massachusetts (8087)
Michigan (323)
Minnesota (628)
Mississippi (5)
Missouri (136)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (2999)
New Mexico (29)
New York (2969)
North Carolina (1470)
North Dakota (8)
Northern California (5488)
Ohio (340)
Oklahoma (21)
Oregon (41)
Pennsylvania (2272)
Puerto Rico (24)
Rhode Island (47)
South America (1137)
South Carolina (65)
South Dakota (1)
Southern California (4389)
Tennessee (174)
Texas (1744)
United States (39992)
Utah (337)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (919)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
730,199 Results for "cdi laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections
November 18, 2025
·
5 min read
Press Releases
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
December 19, 2025
·
7 min read
Press Releases
Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference
September 15, 2025
·
5 min read
Press Releases
Cocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference
August 6, 2025
·
7 min read
Press Releases
Cocrystal Pharma Receives FDA IND Clearance for Challenge Study of Oral Broad-Spectrum Protease Inhibitor CDI-988, a Potential First Antiviral for Norovirus Prevention and Treatment
September 9, 2025
·
4 min read
Press Releases
Acurx Announces Publication in Lancet Microbe of Phase 2b Clinical Trial Data for Ibezapolstat in CDI
June 18, 2025
·
17 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
December 4, 2025
·
1 min read
Business
Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories
CDI Laboratories Inc., the Seromics™ company, announced that Barney E. Saunders Ph.D. has been appointed Chief Executive Officer.
August 2, 2023
·
2 min read
Press Releases
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences - November 12, 2025
November 13, 2025
·
1 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
1 of 73,020
Next
